mobile biopharma-reporter.com
Biopharmaceutical Manufacturing, Upstream, Downstream processing news
News on the biopharmaceutical manufacturing industry, focusing on biologics, technology, upstreamdownstream processing, cell culture and regulations
OVERVIEW
The domain mobile.biopharma-reporter.com currently has a traffic classification of zero (the lower the more traffic). We have crawled twenty pages within the domain mobile.biopharma-reporter.com and found seven websites referencing mobile.biopharma-reporter.com. We have detected one mass communication platforms enjoyed by mobile.biopharma-reporter.com.
Pages Parsed
20Links to this site
7Social Links
1MOBILE.BIOPHARMA-REPORTER.COM TRAFFIC
The domain mobile.biopharma-reporter.com has seen fluctuating quantities of traffic until the end of the year.
Date Range
1 week
1 month
3 months
This Year
Last Year
All time
Date Range
All time
This Year
Last Year
Date Range
All time
This Year
Last Year
Last Month
LINKS TO MOBILE.BIOPHARMA-REPORTER.COM
WHAT DOES MOBILE.BIOPHARMA-REPORTER.COM LOOK LIKE?
MOBILE.BIOPHARMA-REPORTER.COM SERVER
We identified that the main root page on mobile.biopharma-reporter.com took seven hundred and sixty-six milliseconds to load. Our parsers could not discover a SSL certificate, so therefore I consider mobile.biopharma-reporter.com not secure.
Load time
0.766 sec
SSL
NOT SECURE
IP
94.125.166.130
SITE TITLE
Biopharmaceutical Manufacturing, Upstream, Downstream processing newsDESCRIPTION
News on the biopharmaceutical manufacturing industry, focusing on biologics, technology, upstreamdownstream processing, cell culture and regulationsPARSED CONTENT
The domain mobile.biopharma-reporter.com had the following in the web site, "Cell Therapy Manufacturing and Gene Therapy Congress 2016." I observed that the webpage stated " BPI European Summit - Dusseldorf, Germany." They also stated " Biological Production Forum 2014, Ireland. Teva Celltrion deal will double biosimilar sales to 600m. Celltrion deal and multi-million Euro German plant will make it a major second and third wave biosimilars player says Teva. Amgen teams with Immatics on cancer immunotherapies. AGC boasts 44,000L of biomanufacturing capacity on back of recent MA."SEE MORE DOMAINS
invisiblegerbils Just another WordPress.com site
This is your first post. Edit or delete it and start blogging! Blog at WordPress. Create a free website or blog at WordPress.
needhelpwith Just another WordPress.com site
This site is back up. Ok first lesson,On a game called roblox theres scripting and theres a. This site is back up.
Mobile Ad Networks Interstitial eCPM Report- by AdTapsy
Get notified about newest AdTapsy monetization reports and features. Mobile Ad Networks Interstitial eCPM Report. Click countries to view history.
MIUI ADRIA FORUM
By continuing to use this site, you are agreeing to our use of cookies.